1 Min Read
May 18 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA SAYS U.S. FDA APPROVED LOKELMA IN THE U.S. FOR THE TREATMENT OF ADULTS WITH HYPERKALAEMIA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.